

Instance: composition-en-56a32a5ee239fc834b47c10db1faa3fd
InstanceOf: CompositionUvEpi
Title: "Composition for flucelvax Package Leaflet"
Description:  "Composition for flucelvax Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - flucelvax"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Flucelvax Tetra is and what it is used for  </li>
<li>What you need to know before you receive  Flucelvax Tetra  </li>
<li>How Flucelvax Tetra is given  </li>
<li>Possible side effects  </li>
<li>How to store Flucelvax Tetra   </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What flucelvax is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What flucelvax is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Flucelvax Tetra is a vaccine against flu (influenza). Flucelvax Tetra is prepared in cell cultures, and, 
therefore, is egg-free. 
When a person is given the vaccine, the immune system (the body s natural defence system) will 
produce its own protection against the influenza virus. None of the ingredients in the vaccine can 
cause flu. </p>
<p>Flucelvax Tetra is used to prevent flu in adults and children from 2 years of age. </p>
<p>The vaccine targets four strains of influenza virus following the recommendations by the World 
Health Organisation for the 2023/2024 SEASON. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take flucelvax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take flucelvax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>You should not receive Flucelvax Tetra: 
If you are allergic to: 
* the active ingredients or any of the other ingredients of this medicine (listed in section 6) 
* beta-propiolactone, cetyltrimethylammonium bromide, or polysorbate 80, which are trace 
residues from the manufacturing process. </p>
<p>Warnings and precautions<br />
Talk to your doctor, pharmacist or nurse before receiving Flucelvax Tetra. </p>
<p>BEFORE receiving the vaccine 
* Your doctor or nurse will make sure that appropriate medical treatment and supervision is readily 
available in case of a rare anaphylactic reaction (a very severe allergic reaction with symptoms 
such as difficulty in breathing, dizziness, a weak and rapid pulse and skin rash) following the 
administration. This reaction may occur with Flucelvax Tetra as with all vaccines that are injected. 
* You should tell your doctor if you have an acute illness associated with fever. Your doctor may 
decide to delay your vaccination until your fever is gone. </p>
<ul>
<li>You should tell your doctor if your immune system is impaired, or if you are undergoing treatment 
which affects the immune system, e.g. with medicine against cancer (chemotherapy) or 
corticosteroid medicines (see section  Other medicines and Flucelvax Tetra ). </li>
<li>You should tell your doctor if you have a bleeding problem or bruise easily. </li>
<li>Fainting can occur following, or even before, any needle injection, therefore tell the doctor or 
nurse if you fainted with a previous injection. </li>
</ul>
<p>As with all vaccines, Flucelvax Tetra may not fully protect all persons who are vaccinated. </p>
<p>Children aged less than 2 years 
This vaccine is currently not recommended in children aged less than 2 years as safety and efficacy in 
this age group have not been established. </p>
<p>Other medicines and Flucelvax Tetra<br />
Tell your doctor or nurse if you are using, have recently used or might use any other medicines, 
including medicines obtained without a prescription or if you have recently received any other 
vaccine. </p>
<p>Flucelvax Tetra may be given at the same time as other vaccines. </p>
<p>Pregnancy and breast-feeding<br />
Pregnancy 
Tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby. 
Influenza vaccines may be given in any trimester of pregnancy.  </p>
<p>Breast-feeding 
Use of Flucelvax Tetra during breast-feeding has not been studied. No effects on breast fed babies are 
expected. Flucelvax Tetra may be given during breast-feeding. </p>
<p>Driving and using machines 
Flucelvax Tetra has no or negligible effect on your ability to drive and use machines. </p>
<p>Flucelvax Tetra contains sodium chloride and potassium chloride 
This vaccine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially 
 sodium-free . 
This vaccine contains potassium, less than 1 mmol (39 mg) per dose, i.e. essentially  potassium-free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take flucelvax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take flucelvax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Flucelvax Tetra is given to you by your doctor or nurse as an injection into the muscle at the top of the 
upper arm (deltoid muscle) or into the muscle of the upper and outer part of the thigh in young 
children depending on the muscle size. </p>
<p>Adults and children from 2 years of age: </p>
<p>One dose of 0.5 ml </p>
<p>If your child is younger than 9 years of age and has not been previously vaccinated against flu, a 
second dose should be given after at least 4 weeks. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. 
The following side effects have been reported during clinical studies and during general use: </p>
<p>Very serious side effects 
Tell your doctor immediately or go to the casualty department at your nearest hospital if you 
experience the following side effect   you may need urgent medical attention or hospitalisation: </p>
<p>Difficulty in breathing, dizziness, a weak and rapid pulse and skin rash which are symptoms of an 
anaphylactic reaction (a very severe allergic reaction) </p>
<p>Serious side effects 
Tell your doctor immediately if you experience any of the following side effects   you may need 
medical attention: </p>
<p>You feel weak, you have difficulty moving around or you experience numbness or tingling in your 
limbs. These can be symptoms of  Guillain-Barr  syndrome (GBS), an autoimmune disease caused 
by your body s own immune system. 
  Extensive swelling of injected limb </p>
<p>Other side effects 
Very common (may affect more than 1 in 10 people) 
  Injection site pain, bruising, reddening and hardening or swelling at the site of the injection 
  Headache 
  Muscle pain <br />
  Tiredness<br />
  Loss of appetite 
  Irritability (only reported in children from 2 to &lt; 6 years) 
  Sleepiness (only reported in children 2 to &lt; 6 years) 
Hardening or swelling at the site of the injection, headache, muscle pain, and tiredness were common 
in the elderly. 
Bruising at the site of the injection was common in adults, eldery and children 9 to &lt; 18 years. 
Headache was common in the elderly. 
Loss of appetite was common in adults, eldery and children 9 to &lt; 18 years. </p>
<p>Common (may affect up to 1 in 10 people) 
  Nausea, vomiting, diarrhoea<br />
  Joint pain 
  Shivering 
  Change in eating habits (only reported in children from 2 to &lt; 6 years) 
  Fever (&gt; 38 C) 
Vomiting was uncommon in the elderly. 
Fever was uncommon in adults and the elderly. </p>
<p>Not known (frequency cannot be estimated from the available data) 
  Numbness and tingling sensation (paraesthesia) 
  Generalised skin reactions including itching, bumps on the skin (pruritis, urticaria) or non-specific 
rash  </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. By reporting side effects, you can help provide more information on the 
safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store flucelvax"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store flucelvax"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this vaccine out of the sight and reach of children. </p>
<p>Do not use this vaccine after the expiry date which is stated on the label and carton after EXP. The 
expiry date refers to the last day of that month. </p>
<p>Store in a refrigerator (2  C to 8  C). Do not freeze. 
Keep the pre-filled syringe in the outer carton in order to protect from light. </p>
<p>. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Flucelvax Tetra contains  </p>
<p>The active substances are influenza virus surface antigens (haemagglutinin and neuraminidase), 
inactivated, of the following strains*: </p>
<p>A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022 CVR-167) 15 micrograms HA<strong> 
A/Darwin/6/2021 (H3N2)-like strain (A/Darwin/11/2021, wild type) 15 micrograms HA</strong> 
B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) 15 micrograms HA<strong> 
B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type) 15 micrograms HA</strong> </p>
<p>per 0.5 ml dose 
 . 
* 
propagated in Madin Darby Canine Kidney (MDCK) cells (this is the special cell culture in 
which the influenza virus is grown);<br />
** 
haemagglutinin </p>
<p>This vaccine complies with the World Health Organisation (WHO) recommendation (northern 
hemisphere) and EU recommendation for the 2023/2024 SEASON. </p>
<p>The other ingredients are: sodium chloride, potassium chloride, magnesium chloride hexahydrate, 
disodium phosphate dihydrate, potassium dihydrogen phosphate and water for injections. 
(see Section 2   Flucelvax Tetra contains sodium and potassium) </p>
<p>What Flucelvax Tetra looks like and contents of the pack </p>
<p>Flucelvax Tetra is a suspension for injection (injection) in a pre-filled syringe (ready to use syringe).<br />
Flucelvax Tetra is a clear to slightly opalescent suspension. 
A single syringe contains 0.5 ml of suspension for injection. 
Flucelvax Tetra is available in packs containing 1 pre-filled syringe with or without needle or 10 pre-
filled syringes with or without needles. 
Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer 
Seqirus Netherlands B.V. 
Paasheuvelweg 1105BJ Amsterdam 
Netherlands </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Lietuva </p>
<p>Seqirus Netherlands B.V.Nederland/Netherlands 
Tel: +31 (0) 20 204 6<br />
Seqirus Netherlands B.V. <br />
 .: +31 (0) 20 204 6 esk  republika 
Seqirus Netherlands B.V. Nizozemsko 
Tel: +31 (0) 20 204 6Danmark 
Seqirus Netherlands B.V. Holland 
Tlf: +31 (0) 20 204 6Deutschland 
Seqirus GmbH Marburg 
Tel: 08003601Eesti 
Seqirus Netherlands B.V. Holland 
Tel: +31 (0) 20 204 6<br />
WIN MEDICA  . . 
 : 210 7488Espa a 
Seqirus Spain, S.L., Barcelona 
Tel: 937 817 France 
Seqirus Netherlands B.V. Netherlands 
T l: +31 (0) 20 204 6Hrvatska 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6Ireland 
Seqirus UK Limited Maidenhead 
Tel: +44 1628 641  sland 
Seqirus Netherlands B.V. Holland 
S mi: +31 (0) 20 204 6Italia 
Seqirus S.r.l. Siena 
Tel: +39 0577 096<br />
Seqirus Netherlands B.V. <br />
 : +31 (0) 20 204 6Latvija 
Seqirus Netherlands B.V. Nyderlandai 
Tel: +31 (0) 20 204 6Luxembourg/Luxemburg 
Seqirus Netherlands B.V. Netherlands 
T l/Tel: +31 (0) 20 204 6Magyarorsz g 
Seqirus Netherlands B.V. Hollandia 
Tel.: +31 (0) 20 204 6Malta 
Seqirus Netherlands B.V. In-Netherlands 
Tel: +31 (0) 20 204 6Nederland 
Seqirus Netherlands B.V. Amsterdam 
Tel: +31 (0) 20 204 6Norge 
Seqirus Netherlands B.V. Nederland 
Tlf: +31 (0) 20 204 6 sterreich 
Valneva Austria GmbH, Wien 
Tel: +43 1 20620 2Polska 
Seqirus Netherlands B.V. Holandia 
Tel.: +31 (0) 20 204 6Portugal 
Seqirus Netherlands B.V. Pa ses Baixos 
Tel: +31 (0) 20 204 6Rom nia 
Seqirus Netherlands B.V. Olanda 
Tel: +31 (0) 20 204 6Slovenija 
Seqirus Netherlands B.V. Nizozemska 
Tel: +31 (0) 20 204 6Slovensk  republika 
Seqirus Netherlands B.V. Holandsko 
Tel: +31 (0) 20 204 6Suomi/Finland 
Seqirus Netherlands B.V. Alankomaat 
Puh/Tel: +31 (0) 20 204 6Sverige 
Seqirus Netherlands B.V. Nederl nderna 
Tel: +31 (0) 20 204 6Seqirus Netherlands B.V. N derlande 
Tel: +31 (0) 20 204 6This leaflet was last revised in. </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      





                      
Instance: bundlepackageleaflet-en-56a32a5ee239fc834b47c10db1faa3fd
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for flucelvax Package Leaflet for language en"
Description: "ePI document Bundle for flucelvax Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-56a32a5ee239fc834b47c10db1faa3fd"
* entry[0].resource = composition-en-56a32a5ee239fc834b47c10db1faa3fd
                      
                      